<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1699-695X</journal-id>
<journal-title><![CDATA[Revista Clínica de Medicina de Familia]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Clin Med Fam]]></abbrev-journal-title>
<issn>1699-695X</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Española de Medicina de Familia y Comunitaria]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1699-695X2020000300198</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Resistencia antibiótica de Escherichia coli en infecciones urinarias nosocomiales y adquiridas en la comunidad del Sector Sanitario de Huesca 2016-2018]]></article-title>
<article-title xml:lang="en"><![CDATA[Evolution of antibiotic resistance of Escherichia coli in nosocomial urinary tract infections in Primary and Hospital Care in Huesca]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Betrán]]></surname>
<given-names><![CDATA[Ana]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Lavilla]]></surname>
<given-names><![CDATA[María José]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Cebollada]]></surname>
<given-names><![CDATA[Rocío]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Calderón]]></surname>
<given-names><![CDATA[José Manuel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Torres]]></surname>
<given-names><![CDATA[Luís]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital San Jorge Microbiología ]]></institution>
<addr-line><![CDATA[Huesca ]]></addr-line>
<country>España</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Hospital San Jorge Medicina Preventiva ]]></institution>
<addr-line><![CDATA[Huesca ]]></addr-line>
<country>España</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2020</year>
</pub-date>
<volume>13</volume>
<numero>3</numero>
<fpage>198</fpage>
<lpage>202</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S1699-695X2020000300198&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S1699-695X2020000300198&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S1699-695X2020000300198&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Objetivo: Determinar la resistencia in vitro del uropatógeno más frecuente, Escherichia coli, a varios antimicrobianos en nuestro Sector Sanitario y deducir opciones de tratamiento empírico.  Diseño: Estudio epidemiológico descriptivo retrospectivo.  Material y métodos: Desde el 1 de enero de 2016 al 31 de diciembre de 2018 se estudiaron las cepas de E. coli aisladas de urocultivos de pacientes procedentes de Atención Primaria y Hospitalaria del Sector de Huesca. Se procesaron un total de 42004 muestras. Se determinó la sensibilidad a once antibióticos de uso frecuente. Se analizó la existencia de diferencias estadísticamente significativas de sensibilidad en los años estudiados, comparando sus correspondientes intervalos de confianza al 95 % (método de Fisher).  Resultados: E. coli ha sido la bacteria más frecuentemente aislada durante el periodo de estudio. La resistencia se ha mantenido por debajo del 4 % frente a fosfomicina y nitrofurantoína y por debajo del 12% a cefalosporinas de tercera generación. En cefuroxima y amoxicilina-clavulánico se ha observado un significativo aumento de la resistencia en las cepas hospitalarias con respecto a las de la comunidad en este periodo. Los máximos niveles de resistencia (superior al 20%) se encontraron en los antibióticos administrados vía oral y frecuentemente indicados en infecciones urinarias no complicadas: trimetoprim-sulfametoxazol, ciprofloxacino y amoxicilina.  Conclusiones: Estos resultados sugieren que el tratamiento empírico de primera elección para las infecciones urinarias en nuestra área sanitaria podrían ser fosfomicina, nitrofurantoína o cefalosporinas de segunda generación, aunque estas últimas sólo a nivel comunitario, mientras que en hospital su uso sin testar en antibiograma estaría desaconsejado por el porcentaje creciente de resistencias. No se recomendaría como tratamiento de primera elección trimetoprim-sulfametoxazol ni quinolonas.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Objectives: To determine in-vitro resistance of the most frequent uropathogen, Escherichia coli, to several antibiotics in our health sector, and to deduce empirical treatment options.  Design: Retrospective descriptive epidemiological study  Material and methods: E. coli strains isolated from urine cultures of patients from Primary and Hospital Care in Huesca Sector, between 1 January 2016 and 31 December 2018, were studied. A total of 42004 samples were processed. The sensitivity to eleven frequently used antibiotics was determined. The existence of statistically significant differences in sensitivity for the years under study was analyzed, comparing their corresponding 95% confidence intervals (Fisher´s method).  Results: E. coli has been the most frequently isolated bacteria during the study period. Resistance to fosfomycin and nitrofurantoin has remained below 4%, and resistance to third generation cephalosporins below 12%. Regarding cefuroxime and amoxicillin-clavulanic acid, a significant increase in resistance in hospital strains with respect to community strains has been observed in this period. The highest levels of resistance (more than 20%) were found in antibiotics administered orally and frequently indicated in uncomplicated urinary tract infections: trimethoprim-sulfamethoxazole, ciprofloxacin, and amoxicillin.  Conclusions: These results suggest that the first choice empirical treatments for urinary tract infections in our health area are fosfomycin, nitrofurantoin, or second generation cephalosporins. The latter is only at a community level, whereas its use in hospitals without testing in antibiogram is not recommended due to an increasing percentage of resistance. Trimethoprim-sulfamethoxazole or quinolones are not recommended as first choice treatment.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Infección urinaria]]></kwd>
<kwd lng="es"><![CDATA[Resistencia antibiotica]]></kwd>
<kwd lng="es"><![CDATA[Escherichia coli]]></kwd>
<kwd lng="en"><![CDATA[Urinary tract infection]]></kwd>
<kwd lng="en"><![CDATA[Antibiotic resistance]]></kwd>
<kwd lng="en"><![CDATA[Escherichia coli]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="">
<collab>Sociedad Española de Medicina Preventiva y Salud Publica e Higiene</collab>
<source><![CDATA[Estudio de Prevalencia de las Infecciones Nosocomiales en España 2017]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alos]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiología y etiología de la infección urinaria comunitaria: Sensibilidad antimicrobiana de los principales patógenos y significado clínico de la resistencia]]></article-title>
<source><![CDATA[Enferm Infecc Microbiol Clin]]></source>
<year>2005</year>
<volume>23</volume>
<page-range>3-8</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Foxman]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiology of urinary tract infections: incidence, morbidity, and economic costs]]></article-title>
<source><![CDATA[Am J Med]]></source>
<year>2002</year>
<volume>113</volume>
<numero>^s1A</numero>
<issue>^s1A</issue>
<supplement>1A</supplement>
<page-range>S5-13</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gupta]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Scholes]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Stamm]]></surname>
<given-names><![CDATA[WE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women]]></article-title>
<source><![CDATA[J Am Med Assoc]]></source>
<year>1999</year>
<volume>281</volume>
<page-range>736-8</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sánchez Merino]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Guillán Maquieira]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Fuster Foz]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Madrid García]]></surname>
<given-names><![CDATA[FJ]]></given-names>
</name>
<name>
<surname><![CDATA[Jiménez Rodríguez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[García Alonso]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Sensibilidad microbiana de Escherichia coli en infecciones urinarias extrahospitalarias]]></article-title>
<source><![CDATA[Actas Urol Esp]]></source>
<year>2003</year>
<volume>27</volume>
<page-range>783-7</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arslan]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Azap]]></surname>
<given-names><![CDATA[OK]]></given-names>
</name>
<name>
<surname><![CDATA[Ergönül]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Timurkaynak]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<collab>Urinary Tract Infection Study Group</collab>
<article-title xml:lang=""><![CDATA[Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey]]></article-title>
<source><![CDATA[J Antimicrob Chemother]]></source>
<year>2005</year>
<volume>56</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>914-8</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Economou]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Gousia]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Agriculture and food animals as a source of antimicrobial-resistant bacteria]]></article-title>
<source><![CDATA[Infect Drug Resist]]></source>
<year>2015</year>
<volume>8</volume>
<page-range>49</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Andreu]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Planells]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Etiología de la infección urinaria baja adquirida en la comunidad y resistencia de Escherichia coli a los antimicrobianos de primera línea Estudio nacional multicéntrico]]></article-title>
<source><![CDATA[Med Clin (Barc)]]></source>
<year>2008</year>
<volume>130</volume>
<page-range>481-6</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pigrau]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<source><![CDATA[Infección del tracto urinario]]></source>
<year>2013</year>
<publisher-loc><![CDATA[Barcelona ]]></publisher-loc>
<publisher-name><![CDATA[Ed. Salvat]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Junquera]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Loza]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Baquero]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evolución del patrón de sensibilidad de aislados de Escherichia coli en urocultivos procedentes del medio hospitalario y extrahospitalario]]></article-title>
<source><![CDATA[Enferm Infecc Microbiol Clin]]></source>
<year>2005</year>
<volume>23</volume>
<page-range>198-202</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tena]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Glez-Praetorius]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[J C]]></given-names>
</name>
<name>
<surname><![CDATA[Heredero]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Illescas]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Sainz de Baranda]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evolución del patrón de sensibilidad de Escherichia coli en infecciones del tracto urinario diagnosticados en la comunidad durante el período 2003-2007. Estudio multicéntrico en Castilla-La Mancha]]></article-title>
<source><![CDATA[Rev Esp de Quimioter]]></source>
<year>2010</year>
<volume>23</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>36-42</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Palop Larrea]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez-Mir]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Folch Marín]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Colomina Rodríguez]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Sempere Manuel]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Tratamiento empírico de las infecciones genitourinarias e infecciones de transmisión sexual]]></source>
<year>2018</year>
<publisher-name><![CDATA[Fisterra]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mensa]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Gatell]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[García-Sánchez]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[Letang]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[López-Suñé]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Marco]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<source><![CDATA[Guía de Terapéutica Antimicrobiana 2019]]></source>
<year>2019</year>
<publisher-loc><![CDATA[Barcelona ]]></publisher-loc>
<publisher-name><![CDATA[Editorial Antares-Mensa]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
